Participants:0–17 years · 18–64 years
Substances:Allogeneic Peripheral Blood-Derived Cd56+ Natural Killer Cells, Co-Cultured With K562-Mb15-41Bbi Cell Line

Contact Research Centre

Sarcoma+6

Recruiting

Registered drugNo placebo

Study of Trabectedin and Low-Dose Radiation Therapy for Adults and Young Adults with Advanced or Metastatic Soft Tissue and Bone Sarcomas

Registered drugNo placebo

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Trabectedin

Contact Research Centre

Sarcoma+3

Recruiting

Registered drugNo placebo

Study of Pembrolizumab and Cabozantinib for Patients with Advanced Sarcomas: Undifferentiated Pleomorphic Sarcoma, Osteosarcoma, and Ewing Sarcoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cabozantinib

Contact Research Centre

Sarcoma

Not yet recruiting

Registered drugNo placebo

Evaluation of 68Ga-FAPI-46 and Fluor-18-FDG PET/MRI in Paediatric Sarcoma Patients

Registered drugNo placebo

Denmark

Participants:0–17 years
Substances:(S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate

Contact Research Centre

Sarcoma

Not recruiting

Registered drugNo placebo

Study on Advanced Soft-Tissue Sarcoma: Testing Futibatinib and Drug Combination for Patients with Unresectable or Metastatic Conditions

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Capmatinib

Contact Research Centre

Sarcoma

Not recruiting

Registered drugNo placebo

Study on the Effectiveness of Nivolumab, Ipilimumab, and Pazopanib in Patients with Advanced Rare Sarcomas

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Ipilimumab

Contact Research Centre

Sarcoma

Not recruiting

Registered drugNo placebo

Study of Atezolizumab Combined with Radiotherapy in Patients with Operable Soft Tissue Sarcomas

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Find therapies in clinical trials near you

11 trials match your criteria

Sarcoma

Study of GSK5764227 Safety and Efficacy in Adults with Previously Treated Advanced Unresectable or Metastatic Sarcoma

Sarcoma+4

Study of zanidatamab in adult patients with HER2-positive solid tumors (endometrial, colorectal, head & neck, sarcoma) or HER2-mutant non-small cell lung cancer

Sarcoma+18

Study on the Effectiveness and Safety of BAY 2927088 for Patients with Advanced Solid Tumors with HER2 Mutations

Sarcoma

Study on CART45RA-NKG2D Cells for Children, Adolescents, and Young Adults with Advanced Sarcoma

Sarcoma

Study of Activated NK Cells for Treating Sarcomas in Children, Adolescents, and Young Adults

Sarcoma+6

Study of Trabectedin and Low-Dose Radiation Therapy for Adults and Young Adults with Advanced or Metastatic Soft Tissue and Bone Sarcomas

Sarcoma+3

Study of Pembrolizumab and Cabozantinib for Patients with Advanced Sarcomas: Undifferentiated Pleomorphic Sarcoma, Osteosarcoma, and Ewing Sarcoma

Sarcoma

Evaluation of 68Ga-FAPI-46 and Fluor-18-FDG PET/MRI in Paediatric Sarcoma Patients

Sarcoma

Study on Advanced Soft-Tissue Sarcoma: Testing Futibatinib and Drug Combination for Patients with Unresectable or Metastatic Conditions

Sarcoma

Study on the Effectiveness of Nivolumab, Ipilimumab, and Pazopanib in Patients with Advanced Rare Sarcomas

Sarcoma

Study of Atezolizumab Combined with Radiotherapy in Patients with Operable Soft Tissue Sarcomas

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.